Your browser doesn't support javascript.
loading
Drug survival and clinical effectiveness of secukinumab, ixekizumab, brodalumab, guselkumab, risankizumab, tildrakizumab for psoriasis treatment.
Mastorino, Luca; Dapavo, Paolo; Susca, Sara; Cariti, Caterina; Siliquini, Niccolò; Verrone, Anna; Stroppiana, Elena; Ortoncelli, Michela; Quaglino, Pietro; Ribero, Simone.
Afiliação
  • Mastorino L; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Dapavo P; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Susca S; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Cariti C; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Siliquini N; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Verrone A; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Stroppiana E; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Ortoncelli M; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Quaglino P; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Ribero S; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
J Dtsch Dermatol Ges ; 22(1): 34-42, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37926830
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Produtos Biológicos / Anticorpos Monoclonais Humanizados / Anticorpos Monoclonais Limite: Humans / Male Idioma: En Revista: J Dtsch Dermatol Ges Assunto da revista: DERMATOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Produtos Biológicos / Anticorpos Monoclonais Humanizados / Anticorpos Monoclonais Limite: Humans / Male Idioma: En Revista: J Dtsch Dermatol Ges Assunto da revista: DERMATOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália